pDONR223 SARS-CoV-2 S Citations (4)
Originally described in: A Comprehensive, Flexible Collection of SARS-CoV-2 Coding Regions.Kim DK, Knapp JJ, Kuang D, Chawla A, Cassonnet P, Lee H, Sheykhkarimli D, Samavarchi-Tehrani P, Abdouni H, Rayhan A, Li R, Pogoutse O, Coyaud E, van der Werf S, Demeret C, Gingras AC, Taipale M, Raught B, Jacob Y, Roth FP G3 (Bethesda). 2020 Aug 6. pii: g3.120.401554. doi: 10.1534/g3.120.401554. PubMed Journal
Articles Citing pDONR223 SARS-CoV-2 S
| Articles |
|---|
| S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity. Mesquita FS, Abrami L, Sergeeva O, Turelli P, Qing E, Kunz B, Raclot C, Paz Montoya J, Abriata LA, Gallagher T, Dal Peraro M, Trono D, D'Angelo G, van der Goot FG. Dev Cell. 2021 Oct 25;56(20):2790-2807.e8. doi: 10.1016/j.devcel.2021.09.016. Epub 2021 Oct 1. PubMed |
Single-domain near-infrared protein provides a scaffold for antigen-dependent fluorescent nanobodies.
Oliinyk OS, Baloban M, Clark CL, Carey E, Pletnev S, Nimmerjahn A, Verkhusha VV.
Nat Methods. 2022 May 23. pii: 10.1038/s41592-022-01467-6. doi: 10.1038/s41592-022-01467-6.
PubMed
Associated Plasmids |
| Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53. Lee JD, Menasche BL, Mavrikaki M, Uyemura MM, Hong SM, Kozlova N, Wei J, Alfajaro MM, Filler RB, Muller A, Saxena T, Posey RR, Cheung P, Muranen T, Heng YJ, Paulo JA, Wilen CB, Slack FJ. Cell Rep. 2023 Dec 26;42(12):113478. doi: 10.1016/j.celrep.2023.113478. Epub 2023 Nov 21. PubMed |
| The Equal Neutralizing Effectiveness of BNT162b2, ChAdOx1 nCoV-19, and Sputnik V Vaccines in the Palestinian Population. Damour A, Faure M, Landrein N, Ragues J, Ardah N, Dhaidel H, Lafon ME, Wodrich H, Basha W. Vaccines (Basel). 2024 May 3;12(5):493. doi: 10.3390/vaccines12050493. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.